Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis

Summary

This study will characterize the steady state pharmacokinetics of sulfasalazine delayed release tablets in pediatric Juvenile Idiopathic Arthritis patients. Data from this study will fulfill the post approval commitment to the FDA.

Timeline

Start

2010-06

Primary completion

2014-01

Completion

2014-01

Outcome

Outcome not reported

Stopped (Business): “Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study”

Drugs

Indications